|
|
|
Corporate Profile:
Theravance
| Summary: |
| Theravance is focused on small molecule drugs across a number of therapeutic areas with an initial focus on respiratory disease, bacterial infections and gastrointestinal disorders. |
| Address (HQ): |
901 Gateway Blvd.
South San Francisco , CA 94080 |
| Phone #'s (HQ): |
| Main |
(650) 808-6000 |
| Human
Resources |
not known |
| Investor
Relations |
(650) 808-4100 |
| Fax #'s (HQ): |
| Main |
not known |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| Financial
information: |
| THRX |
| Issued United States patents: |
| Issued U.S. patents: 1976-present: patent link. |
| Filed United States patent applications: |
| Filed U.S. patent applications: 2001-present: patent
link. |
| Publications on PubMed: |
| Scientific publications on PubMed with an author from the company: publications
link. |
|
|
|
